← FDA DRUG APPROVALS

FDA ANDA · ANDA205366

LEVOTHYROXINE SODIUM

Sponsor: PH HEALTH

APPLICATION
ANDA205366
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-07
LATEST ACTION
2015-12-07
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

LEVOTHYROXINE SODIUMDiscontinued
LEVOTHYROXINE SODIUM 200MCG/VIAL · POWDER · INTRAVENOUS

Approval history

2015-12-07UNKNOWN · Original · standardTA
2015-12-07UNKNOWN · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →